Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled Study
NCT01769794 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 288
Last updated 2013-01-17
Summary
The study is aimed to evaluate the effectiveness and safety of Jinlianqingre Effervescent Tablets, a traditional Chinese medicine (TCM), in the treatment of Uncomplicated hand, foot, and mouth disease (HFMD).
Conditions
- Hand, Foot and Mouth Disease
Interventions
- DRUG
-
Western therapy
Physical cooling paste or warm bathing, vitamin B, vitamin C. On the basis of the attending physician's judgment, participants were allowed to use Ibuprofen suspension if their body temperature was greater than 38.5℃. Likewise, the need for antibiotics was determined by the attending physicians. The use of acetaminophen or antibiotics was recorded on the case record form
- DRUG
-
JET
4g/tablet, One tablet each time (Taken after dissolved in 50ml boiled water, 3 times daily if body temperature≥38.5℃)
- DRUG
-
Placebo(for JET)
placebos prepared identical in color, taste and consistency to the JET (supplied by Zhongshenghaitian Pharmaceutical, Tianjin, China)
Sponsors & Collaborators
-
Chengdu University of Traditional Chinese Medicine
collaborator OTHER -
Beijing Children's Hospital
collaborator OTHER -
Tianjin infectious disease hospital
collaborator UNKNOWN -
Tangshan infectious disease hospital
collaborator UNKNOWN -
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
collaborator OTHER -
Tianjin Zhongshenghaitian Pharmaceutical Co. Ltd.
collaborator UNKNOWN -
China Academy of Chinese Medical Sciences
lead OTHER
Principal Investigators
-
Boyan Liu, chief physician · China Academy of Chinese Medical Sciences
-
Guoliang Zhang, chief · The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Year
- Max Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2011-10-31
- Completion
- 2011-10-31
Countries
- China
Study Locations
More Related Trials
-
Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection
NCT05672498 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness Study of Integrative Treatment for Pediatric Community Acquired Pneumonia
NCT02362906 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of TCM Capsules Lian Hua Qing Wen Jiao Nang in Mild COVID-19 Patients
NCT05275933 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effectiveness and Clinical Mechanism of Huanglian-Jiedu Decoction in Patients With Intense-exuberant Stomach Fire Syndrome
NCT03469232 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Trial of Chinese Herbal Medicine in the Treatment of Upper Respiratory Tract Infections (URTIs)
NCT00887172 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine and Western Medicine
NCT04189367 ·Status: UNKNOWN ·Phase: PHASE3
-
A Pragmatic Randomized Controlled Trial of Chinese Herbal Medicine for Severe Pandemic H1N1 Influenza
NCT01053533 ·Status: UNKNOWN ·Phase: NA
-
Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19
NCT04278963 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Chinese Medicine for Patients With LCOVID-19 Symptoms
NCT04924881 ·Status: UNKNOWN ·Phase: PHASE2
-
China Cimicifuga Trial of Climacteric Complaint Control
NCT00622986 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer
NCT02794493 ·Status: COMPLETED ·Phase: PHASE3
-
An Innovative Chinese Herbal Formula for Macular Edema
NCT05122702 ·Status: UNKNOWN ·Phase: PHASE2
-
A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection
NCT02539277 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Traditional Chinese Medicine on Outcomes in Patients With Severe Pneumonia
NCT03185923 ·Status: UNKNOWN ·Phase: PHASE3
-
Traditional Chinese Medicine for Treatment of Chronic Heart Failure
NCT01939236 ·Status: COMPLETED ·Phase: PHASE2
-
Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study
NCT00936013 ·Status: UNKNOWN ·Phase: PHASE4
-
Jinhua Qinggan Granules in the Treatment of COVID-19
NCT04723524 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Efficacy and Safety of Modified Qing-Zao-Jiu-Fei Decoction on Pneumoconiosis Patients
NCT07178184 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19
NCT05787327 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease
NCT01486186 ·Status: UNKNOWN ·Phase: PHASE2
-
Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine
NCT02937207 ·Status: UNKNOWN ·Phase: PHASE2
-
Traditional Chinese Medicine for Severe COVID-19
NCT04323332 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Traditional Chinese Medicine of Severe COVID-19
NCT06714032 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty
NCT02650141 ·Status: COMPLETED ·Phase: NA
-
Chinese Medicine for Treating Chronic Pharyngolaryngitis
NCT05665777 ·Status: UNKNOWN ·Phase: PHASE2